Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Agilon Health, Inc. (AGL : NYSE)

• Company Description    agilon health inc. which partners with primary care physicians to provide healthcare services. agilon health inc. is based in CA, United States. Number of Employees: 1,076

• Price / Volume Information    Yesterday's Closing Price: $0.70 Daily Weekly Monthly 20 Day Moving Average: 8,997,482 shares Shares Outstanding: 414.58 (millions) Market Capitalization: $289.05 (millions) Beta: 0.05 52 Week High: $6.08 52 Week Low: $0.68 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -31.65% -31.50% 12 Week -34.23% -36.69% Year To Date -63.31% -67.89%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 440 Polaris Parkway Suite 550 - Westerville,OH 43082 USA ph: 562-256-3800 fax: - investors@agilonhealth.com http://agilonhealth.com

• General Corporate Information    Officers Steven J. Sell - Chief Executive Officer and President Ronald A. Williams - Chairman Ravi Sachdev - Vice Chairman Jeffrey Schwaneke - Chief Financial Officer Timothy Gertsch - Chief Accounting Officer Peer Information Agilon Health, Inc. (CHCR) Agilon Health, Inc. (ESRX) Agilon Health, Inc. (MYDP) Agilon Health, Inc. (COR) Agilon Health, Inc. (GBCS) Agilon Health, Inc. (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 00857U107 SIC: 8090 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 02/24/26 Share - Related Items Shares Outstanding: 414.58 Most Recent Split Date: (:1) Beta: 0.05 Market Capitalization: $289.05 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.19 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.68 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 6.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: 13.34% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 02/24/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.94 Price/Cash Flow: - Price / Sales: 0.05 EPS Growth vs. Year Ago Period: 6.90% vs. Previous Quarter: -8.00% Sales Growth vs. Year Ago Period: -1.08% vs. Previous Quarter: 2.89% ROE 09/30/25 - -75.92 06/30/25 - -66.76 03/31/25 - -45.47 ROA 09/30/25 - -18.35 06/30/25 - -17.47 03/31/25 - -12.76 Current Ratio 09/30/25 - 1.08 06/30/25 - 1.16 03/31/25 - 1.20 Quick Ratio 09/30/25 - - 06/30/25 - 1.16 03/31/25 - 1.20 Operating Margin 09/30/25 - -5.44 06/30/25 - -5.53 03/31/25 - -4.22 Net Margin 09/30/25 - -5.24 06/30/25 - -5.35 03/31/25 - -4.04 Pre-Tax Margin 09/30/25 - -5.46 06/30/25 - -5.55 03/31/25 - -4.24 Book Value 09/30/25 - 0.74 06/30/25 - 0.99 03/31/25 - 1.21 Inventory Turnover 09/30/25 - - 06/30/25 - - 03/31/25 - - Debt-to-Equity 09/30/25 - 0.00 06/30/25 - 0.00 03/31/25 - 0.00 Debt-to-Capital 09/30/25 - 0.00 06/30/25 - 0.00 03/31/25 - 0.00

Powered by Zacks Investment Research ©